Koyfin Home > Directory > Health Care > Antares Pharma > Total Debt / Equity

Antares Pharma Total Debt / Equity Chart (ATRS)

Antares Pharma annual/quarterly Total Debt / Equity from 2017 to 2019. Debt to equity is a measure of leverage in a company and expressed as a ratio of the total debt relative to book value of equity.
  • Antares Pharma Total Debt / Equity for the quarter ending September 09, 2019 was $103m a 37.26% increase of 38m year over year
  • Antares Pharma Total Debt / Equity for the last 12 months ending September 09, 2019 was $103m a 37.26% increase of 38m year over year
  • Antares Pharma Annual Total Debt / Equity for 2018 was $64m a -15.02% decrease of -10m from 2017
  • Antares Pharma Annual Total Debt / Equity for 2017 was $74m
Other Ratios Metrics:
  • Antares Pharma Total Debt / Capital for the quarter ending December 12, 2018 was $39m a -19.64% decrease of -8m year over year
  • Antares Pharma Other Liabilities for the quarter ending September 09, 2018 was $0m a 0.00% decrease of 0m year over year
View Chart On Koyfin

Quarterly ATRS Total Debt / Equity Data

09/2019$103m
06/2019$103m
03/2019$64m
12/2018$64m
09/2018$103m
06/2018$101m
03/2018$88m
12/2017$74m
09/2017$69m
06/2017$61m

Annual ATRS Total Debt / Equity Data

2018$64m
2017$74m